Close

Sri Trang Group accelerates Covid inoculation program

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Pressing ahead with its campaign to provide inoculation to all Southeast Asia based employees of the Sri Trang Group of Companies against Covid-19 with Sinopharm vaccine, provided by the Chulabhorn Royal Academy, Sri Trang Gloves (Thailand) PCL reached its goal of 100% jabs for its entire workforce of 11,000 employees in production plants and Southeast Asia offices. The second jabs will be given at the end of July. Other companies in the group will continue their inoculation programs where permitted until the goal is achieved, demonstrating the group’s commitment to employee welfare.

Most recently, Veerasith Sinchareonkul, Executive Director of Sri Trang Agro-Industry PCL (STA), and Jarinya Jirojkul, CEO of Sri Trang Gloves (Thailand) PCL, pledged to implement the group’s ESG policy, which pays special attention to sustainability in business while treating employees with fairness in accordance with human rights and transparency principles. The companies have launched the Covid-19 vaccination program for all Southeast Asia based employees and their family members as well as select employees of suppliers and trading partners.

At the same time, the Sri Trang Group will earnestly continue to acquire additional doses of alternative vaccines for its employees and families in Thailand and abroad, as well as select members in its supply chain, to build confidence for all concerned and to help these countries overcome the current Covid-19 crisis as soon as possible.

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back